The best allergy medication for athletes must balance effective symptom control with minimal impact on performance, coordination, and anti-doping compliance. Allergic conditions — including hay fever, allergic rhinitis, urticaria, and exercise-induced reactions — are common among both recreational and competitive athletes in the UK, and poorly managed symptoms can disrupt training, impair sleep, and reduce competitive output. From choosing between sedating and non-sedating antihistamines to understanding WADA prohibited substances, navigating allergy treatment in sport requires careful consideration. This guide covers the most suitable options available in the UK, with practical advice on working with your GP, pharmacist, and sports medicine team.
Summary: The best allergy medications for athletes are non-sedating antihistamines (such as fexofenadine, bilastine, or loratadine) combined with intranasal corticosteroids, as these provide effective symptom control with minimal sedation and are not prohibited under WADA anti-doping regulations.
- Non-sedating second-generation antihistamines (fexofenadine, bilastine, loratadine, cetirizine) are preferred over first-generation agents, which impair reaction time, coordination, and cognitive performance.
- Intranasal corticosteroids (e.g., fluticasone, mometasone) are first-line for persistent allergic rhinitis per NICE and ARIA guidance, and are not prohibited under WADA rules.
- Pseudoephedrine, found in some over-the-counter cold and allergy remedies, is prohibited in-competition above a urinary threshold of 150 micrograms per millilitre — athletes must check all product ingredients via Global DRO.
- Exercise-induced anaphylaxis is a potentially life-threatening condition; athletes at risk should carry two prescribed adrenaline auto-injectors and seek specialist allergy assessment.
- Athletes should trial any new antihistamine during low-intensity training before competition days, and consult their GP or pharmacist to ensure their regimen is both effective and anti-doping compliant.
- The MHRA Yellow Card scheme should be used to report any suspected side effects from allergy medications.
Table of Contents
- How Allergies Affect Athletic Performance and Training
- Antihistamines and Allergy Treatments Available in the UK
- Sedating vs Non-Sedating Antihistamines: What Athletes Should Know
- WADA Prohibited Substances and UK Sport Regulations for Allergy Medication
- Advice From Your GP or Pharmacist on Managing Allergies in Sport
- When to Seek Further Assessment for Exercise-Related Allergic Symptoms
- Frequently Asked Questions
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
How Allergies Affect Athletic Performance and Training
Allergic conditions — including hay fever (allergic rhinitis), asthma, urticaria, and exercise-induced allergic reactions — can significantly impair an athlete's ability to train and compete. Symptoms such as nasal congestion, sneezing, itchy eyes, and bronchospasm may increase airway resistance and disrupt sleep quality, both of which can affect physical performance. Persistent allergic rhinitis has been associated in some studies with reduced concentration and increased perceived effort during exercise, though the magnitude of these effects varies between individuals.
For outdoor athletes, pollen seasons present a particular challenge. In the UK, tree pollen typically peaks from February to June, grass pollen from May to July, and mould spores from July to September (Met Office; Allergy UK). Indoor athletes are not immune — dust mites, animal dander, and mould in sports facilities are common triggers. Monitoring local pollen counts via the Met Office or Allergy UK can help athletes plan training schedules accordingly.
It is also worth distinguishing between exercise-induced bronchoconstriction (EIB) — airway narrowing triggered by exercise, which can occur with or without underlying asthma — and asthma itself. EIB is common in athletes and may warrant objective assessment (e.g., spirometry or eucapnic voluntary hyperpnoea testing) if symptoms are atypical or treatment-resistant.
A less well-recognised but clinically important condition is exercise-induced anaphylaxis (EIAn), where physical exertion itself acts as a trigger for systemic allergic reactions. This may occur independently or in combination with a food allergen consumed before exercise. Athletes experiencing urticaria, angioedema, or cardiovascular symptoms during training should be assessed promptly, as this condition carries serious risk if unmanaged.
Effective allergy control not only reduces symptom burden but can help restore training consistency, sleep quality, and competitive performance.
Antihistamines and Allergy Treatments Available in the UK
In the UK, a range of allergy treatments is available through pharmacies, on prescription, or via NHS services. The most commonly used medications include:
-
Oral antihistamines (e.g., cetirizine, loratadine, fexofenadine, bilastine, desloratadine) — available over the counter or on prescription for symptomatic relief of hay fever, urticaria, and allergic rhinitis
-
Intranasal corticosteroids (e.g., fluticasone, beclometasone, mometasone) — recommended as first-line treatment for persistent or moderate-to-severe allergic rhinitis in UK primary care (NICE CKS: Allergic rhinitis; ARIA guideline), as they address nasal inflammation rather than simply masking symptoms
-
Antihistamine eye drops (e.g., azelastine, olopatadine) — useful for athletes with prominent ocular symptoms
-
Leukotriene receptor antagonists (e.g., montelukast) — may be prescribed for allergic rhinitis with co-existing asthma. The MHRA Drug Safety Update (April 2019) advises that patients and carers should be counselled about the risk of neuropsychiatric reactions (including sleep disturbances, mood changes, and suicidal ideation) and that the benefits and risks should be reviewed regularly
-
Allergen immunotherapy — available on the NHS for selected patients with severe, refractory allergic rhinitis or venom allergy; this involves gradual desensitisation and may offer long-term benefit
For athletes with allergic asthma or EIB, inhaled corticosteroids (ICS) and short-acting beta-2 agonists (SABAs) such as salbutamol remain central to management. Current BTS/SIGN and NICE guidance (NG80) also supports ICS–formoterol combination inhalers as both maintenance and reliever therapy (MART) in appropriate patients. Athletes should discuss the most suitable regimen with their GP or asthma nurse, and anti-doping implications are addressed in a later section.
Nasal saline irrigation is a non-pharmacological adjunct that can reduce allergen load in the nasal passages and is safe for all athletes. Identifying and minimising exposure to specific triggers — through pollen forecasts, training schedule adjustments, or appropriate protective eyewear — should complement any pharmacological approach.
If you experience suspected side effects from any allergy medication, these can be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.
Sedating vs Non-Sedating Antihistamines: What Athletes Should Know
Antihistamines work by competitively blocking H1 histamine receptors, thereby reducing the allergic response. However, not all antihistamines have the same effects on the central nervous system, and this distinction is critically important for athletes.
First-generation (sedating) antihistamines — such as chlorphenamine and promethazine — readily cross the blood-brain barrier. This can result in:
-
Drowsiness and sedation
-
Impaired psychomotor function and reaction time
-
Reduced coordination and cognitive performance
-
Potential next-day impairment even after a single evening dose
These effects make first-generation antihistamines poorly suited to athletes, particularly those in sports requiring precision, rapid decision-making, or complex motor skills. They should generally be avoided during training and competition periods.
Second-generation (non-sedating) antihistamines — including cetirizine, loratadine, fexofenadine, bilastine, and desloratadine — have much lower CNS penetration and are significantly less likely to cause sedation at standard doses, as reflected in their Summary of Product Characteristics (SmPCs) and BNF entries. Of these, fexofenadine and bilastine are considered to have a particularly low sedation risk, though comparative effects are dose- and person-dependent and individual responses vary.
It is worth noting that cetirizine, while classified as non-sedating, can cause mild drowsiness in some individuals, particularly at higher doses. Even non-sedating antihistamines may impair a small number of users. Athletes should trial any new antihistamine during a low-intensity training period before using it on competition days.
Intranasal antihistamines such as azelastine act locally with minimal systemic absorption, making them a useful option for athletes who wish to avoid even the small sedation risk associated with oral agents. On rare occasions, some systemic absorption may still occur.
Overall, non-sedating oral antihistamines combined with intranasal corticosteroids represent the most evidence-based and performance-compatible approach for most athletes (NICE CKS: Allergic rhinitis; ARIA guideline).
WADA Prohibited Substances and UK Sport Regulations for Allergy Medication
Athletes competing at national or international level must be aware that some allergy-related medications are subject to anti-doping regulations governed by the World Anti-Doping Agency (WADA) and administered in the UK through UK Anti-Doping (UKAD). The WADA Prohibited List is updated annually; athletes should always verify the current status of any medication before use. Inadvertent doping violations due to allergy medication are a recognised risk, and strict liability applies regardless of intent.
Key considerations include:
-
Oral and injectable corticosteroids are prohibited in-competition under the WADA Prohibited List. Injectable corticosteroids also have specific washout period considerations; athletes should consult UKAD or WADA guidance for current details. Intranasal and inhaled corticosteroids are not prohibited and do not require a Therapeutic Use Exemption (TUE), making them safe choices for athletes.
-
Beta-2 agonists used for asthma are subject to specific rules. Salbutamol is permitted by inhalation up to 1,600 micrograms per 24 hours, with a urinary decision limit of 1,000 nanograms per millilitre. Formoterol is permitted by inhalation up to 54 micrograms per 24 hours. Terbutaline is prohibited unless a TUE has been granted. Athletes using permitted beta-2 agonists should ensure they are prescribed and documented appropriately, and should verify current thresholds on the WADA Prohibited List, as these may change.
-
Pseudoephedrine, found in some over-the-counter cold and allergy remedies, is prohibited in-competition above a urinary threshold of 150 micrograms per millilitre. Athletes must carefully check the ingredients of any combination product before use.
-
Standard antihistamines (cetirizine, loratadine, fexofenadine, bilastine) are not prohibited under current WADA regulations.
Athletes should use the Global DRO (Drug Reference Online) tool — available at globaldro.com — to check the status of any medication before use. When a prohibited medication is medically necessary, a TUE application should be submitted in advance through UKAD. Consulting a sports medicine physician familiar with anti-doping regulations is strongly advisable for any athlete with complex allergy or asthma management needs.
Advice From Your GP or Pharmacist on Managing Allergies in Sport
A GP or community pharmacist is well placed to help athletes develop a safe and effective allergy management plan. In the UK, pharmacists can recommend and supply a range of over-the-counter antihistamines and nasal sprays without a prescription, and can advise on appropriate use, dosing, and potential interactions with other medications.
When consulting a GP, athletes should be open about their sport, training schedule, and competition calendar. This allows the clinician to tailor treatment to minimise performance impact and ensure anti-doping compliance. Useful points to raise include:
-
Timing of symptoms — whether they are seasonal, perennial, or exercise-triggered
-
Specific triggers identified through symptom diaries or allergy testing
-
Previous treatments tried and their effectiveness or side effects
-
Competition dates, so that any new medication can be trialled well in advance
-
Any over-the-counter combination products being used — some contain pseudoephedrine, which is prohibited in-competition; always verify ingredients on Global DRO
GPs can refer patients for NHS allergy testing (skin prick testing or specific IgE blood tests) to confirm sensitisation and guide targeted management. Athletes with asthma or suspected EIB should have an up-to-date Personal Asthma Action Plan and, where appropriate, objective assessment of lung function (peak flow or spirometry) in line with NICE (NG80) and BTS/SIGN guidance. For athletes with confirmed allergic rhinitis that is inadequately controlled with standard therapy, referral to an NHS allergy clinic or ENT specialist may be appropriate.
When using intranasal corticosteroid sprays, direct the nozzle away from the nasal septum (towards the outer wall of the nostril) and tilt the head slightly forward to improve deposition and reduce the risk of epistaxis or irritation. Some athletes find it more comfortable to use their nasal spray after exercise rather than immediately before.
Pharmacists can also advise on non-pharmacological measures such as wraparound sunglasses to reduce pollen exposure, showering after outdoor training, and monitoring local pollen counts via the Met Office or Allergy UK. Combining these practical strategies with appropriate medication often produces better outcomes than medication alone, and reduces the total drug burden — an important consideration for athletes mindful of anti-doping obligations.
If you experience any suspected side effects from allergy medication, report these via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.
When to Seek Further Assessment for Exercise-Related Allergic Symptoms
Whilst most allergy symptoms in athletes are manageable with standard treatments, certain presentations warrant prompt medical assessment. Athletes and their support teams should be aware of the following red flag symptoms that require urgent or specialist evaluation:
-
Anaphylaxis during or after exercise — including urticaria, angioedema, throat tightening, hypotension, or collapse — is a medical emergency. Call 999 immediately and use an adrenaline auto-injector without delay if one is available. Athletes at risk of anaphylaxis should be prescribed two adrenaline auto-injectors (e.g., EpiPen, Jext, or Emerade) and trained in their use, in line with Resuscitation Council UK and NICE guidance on anaphylaxis management.
-
Worsening breathlessness or wheeze during exercise that is not adequately controlled with a reliever inhaler
-
Symptoms occurring at rest as well as during exercise, which may suggest a more complex or systemic allergic condition
-
Recurrent episodes of unexplained urticaria or facial swelling during training
Exercise-induced anaphylaxis, as noted earlier, is a distinct and potentially life-threatening condition. It may be food-dependent (triggered only when a specific food is consumed within a few hours of exercise) or food-independent. Pending specialist assessment, athletes with suspected food-dependent EIAn are generally advised to avoid known trigger foods for at least four to six hours before exercise. Diagnosis requires specialist allergy assessment, and management typically involves carrying two adrenaline auto-injectors, exercising with a companion, and avoiding known triggers.
Athletes with poorly controlled asthma should be reviewed by their GP or an asthma nurse to ensure their management plan is optimised in line with current NICE (NG80) and BTS/SIGN guidance, including a written Personal Asthma Action Plan.
Inducible laryngeal obstruction (ILO) — previously referred to as vocal cord dysfunction — can mimic exercise-induced asthma and is worth considering in athletes with atypical or treatment-resistant respiratory symptoms during exertion. Referral to an appropriate specialist (allergy, ENT, or speech and language therapy) may be warranted.
In summary, most athletes with allergies can train and compete effectively with the right combination of evidence-based medication, practical trigger avoidance, and informed professional support. Early assessment and a proactive management plan are key to minimising the impact of allergic conditions on athletic performance and long-term health.
Frequently Asked Questions
Which antihistamine is best for athletes who need to stay alert during training?
Fexofenadine and bilastine are considered the least sedating antihistamines currently available in the UK, making them particularly suitable for athletes who need to maintain concentration and reaction speed. Both are available on prescription, and fexofenadine is also available over the counter; athletes should trial either medication during a low-intensity session before using it on a competition day to check their individual response.
Is cetirizine safe to take before a race or competition?
Cetirizine is a non-sedating antihistamine and is not prohibited under WADA regulations, but it can cause mild drowsiness in some individuals, particularly at higher doses. Athletes should test their personal response to cetirizine during training rather than taking it for the first time on a competition day, and may wish to consider fexofenadine or bilastine if any sedation is noticed.
Are any common allergy medications banned under WADA anti-doping rules?
Standard antihistamines such as cetirizine, loratadine, fexofenadine, and bilastine are not prohibited under current WADA regulations, but pseudoephedrine — found in many over-the-counter cold and allergy combination products — is banned in-competition above a urinary threshold of 150 micrograms per millilitre. Oral and injectable corticosteroids are also prohibited in-competition, whereas intranasal and inhaled corticosteroids are permitted without a Therapeutic Use Exemption (TUE).
What is the difference between exercise-induced bronchoconstriction and asthma in athletes?
Exercise-induced bronchoconstriction (EIB) refers specifically to airway narrowing triggered by physical exertion and can occur in athletes who do not have underlying asthma, whereas asthma is a chronic inflammatory airway condition that may be worsened by exercise among other triggers. EIB is common in competitive athletes and may require objective testing such as spirometry or eucapnic voluntary hyperpnoea if symptoms are atypical or do not respond to standard treatment.
Can I use a nasal steroid spray for hay fever if I compete in sport?
Yes — intranasal corticosteroid sprays such as fluticasone, beclometasone, and mometasone are not prohibited under WADA rules and do not require a Therapeutic Use Exemption, making them a safe and effective first-line option for athletes with allergic rhinitis. To get the best results and reduce the risk of nosebleeds, direct the nozzle towards the outer wall of the nostril rather than the nasal septum, and tilt your head slightly forward when applying.
How do I get the best allergy medication for my sport on the NHS?
Start by speaking to your GP or community pharmacist, who can recommend or prescribe appropriate non-sedating antihistamines and nasal sprays, and refer you for NHS allergy testing if needed to identify your specific triggers. When booking your appointment, tell your clinician about your sport, training schedule, and competition dates so they can tailor your treatment plan and ensure it is anti-doping compliant — and always check any medication on the Global DRO tool at globaldro.com before use.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
